CareDx Inc.

23.48-2.59-9.93%Vol 1.33M1Y Perf -67.56%
Aug 9th, 2022 16:00 DELAYED
BID22.11 ASK23.72
Open25.29 Previous Close26.07
Pre-Market- After-Market23.16
 - -  -0.32 -1.36%
Target Price
45.67 
Analyst Rating
Strong Buy 1.50
Potential %
94.51 
Finscreener Ranking
★★★★     53.72
Insiders Trans % 3/6/12 mo.
-100/-100/-91 
Value Ranking
★★★★     56.10
Insiders Value % 3/6/12 mo.
-100/-100/-95 
Growth Ranking
★★★★     57.05
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-94 
Income Ranking
 —    -
Price Range Ratio 52W %
6.60 
Earnings Rating
Strong Sell
Market Cap1.26B 
Earnings Date
4th Aug 2022
Alpha0.07 Standard Deviation0.24
Beta0.91 

Today's Price Range

21.7725.57

52W Range

19.3582.03

5 Year PE Ratio Range

-93.20-3.00

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-4.16%
1 Month
-10.59%
3 Months
1.47%
6 Months
-46.91%
1 Year
-67.56%
3 Years
-5.21%
5 Years
1 652.24%
10 Years
-

TickerPriceChg.Chg.%
CDNA23.48-2.5900-9.93
AAPL164.920.05000.03
GOOG117.50-0.6400-0.54
MSFT282.301.98000.71
XOM90.591.64001.84
WFC43.400.21000.49
JNJ170.18-0.0200-0.01
FB196.640.99000.51
GE74.93-0.2500-0.33
JPM115.381.03000.90
 
ProfitabilityValueIndustryS&P 500US Markets
66.70
-15.50
-11.40
-46.40
-19.96
RevenueValueIndustryS&P 500US Markets
234.23M
4.40
44.98
48.20
Earnings HistoryEstimateReportedSurprise %
Q02 2022-0.30-0.41-36.67
Q01 2022-0.30-0.37-23.33
Q04 2021-0.19-0.31-63.16
Q03 2021-0.14-0.23-64.29
Q02 2021-0.09-0.0455.56
Q01 2021-0.14-0.0192.86
Q04 2020-0.12-0.0741.67
Q03 2020-0.19-0.0668.42
Earnings Per EndEstimateRevision %Trend
6/2022 QR-0.30-20.00Negative
9/2022 QR-0.30-50.00Negative
12/2022 FY-1.22-32.61Negative
12/2023 FY-0.74-15.63Negative
Next Report Date-
Estimated EPS Next Report-0.30
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume1.33M
Shares Outstanding53.46K
Shares Float52.29M
Trades Count18.58K
Dollar Volume31.23M
Avg. Volume850.40K
Avg. Weekly Volume953.54K
Avg. Monthly Volume718.23K
Avg. Quarterly Volume879.42K

CareDx Inc. (NASDAQ: CDNA) stock closed at 23.48 per share at the end of the most recent trading day (a -9.93% change compared to the prior day closing price) with a volume of 1.33M shares and market capitalization of 1.26B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 475 people. CareDx Inc. CEO is Reginald Seeto.

The one-year performance of CareDx Inc. stock is -67.56%, while year-to-date (YTD) performance is -48.37%. CDNA stock has a five-year performance of 1652.24%. Its 52-week range is between 19.345 and 82.03, which gives CDNA stock a 52-week price range ratio of 6.60%

CareDx Inc. currently has a PE ratio of -24.10, a price-to-book (PB) ratio of 2.66, a price-to-sale (PS) ratio of 4.91, a price to cashflow ratio of 1 429.20, a PEG ratio of 2.32, a ROA of -9.38%, a ROC of -10.26% and a ROE of -10.99%. The company’s profit margin is -19.96%, its EBITDA margin is -11.40%, and its revenue ttm is $234.22 Million , which makes it $4.40 revenue per share.

Of the last four earnings reports from CareDx Inc., there were 0 positive earnings surprise and 4 negative earnings surprise. The company has EPS estimate of $-0.30 for the next earnings report. CareDx Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for CareDx Inc. is Strong Buy (1.5), with a target price of $45.67, which is +94.51% compared to the current price. The earnings rating for CareDx Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

CareDx Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

CareDx Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 20.22, ATR14 : 2.27, CCI20 : -36.44, Chaikin Money Flow : 0.00, MACD : 0.25, Money Flow Index : 55.37, ROC : 1.29, RSI : 32.96, STOCH (14,3) : 30.88, STOCH RSI : 0.50, UO : 55.13, Williams %R : -69.12), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of CareDx Inc. in the last 12-months were: Ankur Dhingra (Buy at a value of $211 694), Arthur A. Torres (Buy at a value of $28 572), George W. Bickerstaff (Sold 25 000 shares of value $977 673 ), Grace Colon (Sold 6 572 shares of value $167 315 ), Michael D. Goldberg (Option Excercise at a value of $4 270), Michael D. Goldberg (Sold 3 500 shares of value $155 402 ), Peter Maag (Option Excercise at a value of $1 163 373), Peter Maag (Sold 90 000 shares of value $4 840 585 ), Reginald Seeto (Option Excercise at a value of $299 958), Reginald Seeto (Sold 23 089 shares of value $967 232 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (75.00 %)
4 (80.00 %)
4 (80.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (25.00 %)
1 (20.00 %)
1 (20.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.50
Strong Buy
1.40
Strong Buy
1.40

CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey, and is a leading provider of genomics-based information for transplant patients. Its primary operations are in Brisbane, California; Omaha, Nebraska; Fremantle, Australia and Stockholm, Sweden.

CEO: Reginald Seeto

Telephone: +1 415 287-2300

Address: 1 Tower Place, South San Francisco 94080, CA, US

Number of employees: 475

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

73%27%

Bearish Bullish

50%50%

Bearish Bullish

61%39%

TipRanks News for CDNA

Sat, 07 May 2022 03:40 GMT CareDx (CDNA) Gets a Buy Rating from BTIG

- TipRanks. All rights reserved.

Tue, 11 Jan 2022 11:26 GMT CareDx (CDNA) Gets a Hold Rating from H.C. Wainwright

- TipRanks. All rights reserved.

Fri, 07 Jan 2022 11:25 GMT Analysts Offer Insights on Healthcare Companies: CareDx (CDNA), Biohaven Pharmaceutical Holding Co (BHVN) and Liquidia Technologies (LQDA)

- TipRanks. All rights reserved.

News

Stocktwits